← Leaderboards
Hakho Lee
Massachusetts General Hospital
$15,122,007
Attributed
$28,586,143
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2012–25$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,586,143 · 14
By mechanism
R01$18,977,117 · 7
U01$7,867,241 · 3
R21$1,510,372 · 3
R61$231,413 · 1
Top collaborators
- Cesar M Castro18 shared
- Johan Skog12 shared
- Bob S Carter9 shared
- Daniela M Dinulescu5 shared
- Kwonmoo Lee3 shared
- Gurudutt Pendyala2 shared
- Leonora Balaj1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jayaraj Rajagopal$18,059,032
- Jianren Mao$21,748,037
- Cesar M Castro$5,964,176
- Vladimir Vinarsky$795,814
- Charles P Lin$25,566,556
Others in their field
Top investigators on “Monitor”
- Jeffrey P Krischer · University Of South Florida$631,818,376
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$476,087,269
- Bambra Strokes · Ppd Development Lp$461,655,950
- David Heimbrook · Leidos Biomedical Research, Inc.$367,240,481
- Lawrence Corey · Fred Hutchinson Cancer Center$302,301,802
Research focus
MonitorMolecularDetectionCellsSamplingMalignant NeoplasmsDiagnosticTechnologyProteinsDesignInnovationMultidisciplinaryLaboratoriesExtracellular VesiclesNucleic AcidsExosomeAdoptedResourcesMolecular AnalysisLiquid BiopsyPerformanceMassachusettsGeneral HospitalsProtocols Documentation
Grant awards (51)
Empowering cancer detection and monitoring with CampEx - CRISPR-accelerated molecular profiling of Extracellular vesicles$2,855,619
R01 · FY2025 · CA · contact PI
Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array$941,221
U01 · FY2025 · CA · contact PI
High-throughput Phenotyping of iPSC-derived Airway Epithelium by Multiscale Machine Learning Microscopy$780,300
R01 · FY2025 · HL
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach$269,601
U01 · FY2025 · CA
Streamlining sample preparation with high throughput SpinEx (Separation processing integration for Extracellular vesicles)$231,413
R61 · FY2025 · CA · contact PI
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach$126,580
U01 · FY2025 · CA
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach$124,429
U01 · FY2025 · CA
Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array$894,161
U01 · FY2024 · CA · contact PI
High-throughput Phenotyping of iPSC-derived Airway Epithelium by Multiscale Machine Learning Microscopy$759,296
R01 · FY2024 · HL
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer$629,224
R01 · FY2024 · CA
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring$578,593
R01 · FY2024 · CA
Standardized Molecular Analyses of Glioma EVs$557,524
R01 · FY2024 · CA
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach$527,535
U01 · FY2024 · CA
3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids$223,840
R21 · FY2024 · CA · contact PI
Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array$877,641
U01 · FY2023 · CA · contact PI
High-throughput Phenotyping of iPSC-derived Airway Epithelium by Multiscale Machine Learning Microscopy$781,190
R01 · FY2023 · HL
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring$605,638
R01 · FY2023 · CA
Standardized Molecular Analyses of Glioma EVs$577,860
R01 · FY2023 · CA
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach$574,748
U01 · FY2023 · CA
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer$433,516
R01 · FY2023 · CA
3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids$192,424
R21 · FY2023 · CA · contact PI
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer$649,094
R01 · FY2022 · CA
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring$614,253
R01 · FY2022 · CA
Standardized Molecular Analyses of Glioma EVs$602,790
R01 · FY2022 · CA
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$573,531
U01 · FY2022 · CA · contact PI
Clinical platform for high-throughput analyses of extracellular vesicles$572,891
R01 · FY2022 · CA · contact PI
3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids$196,350
R21 · FY2022 · CA · contact PI
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$746,693
U01 · FY2021 · CA · contact PI
High throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancer$662,338
R01 · FY2021 · CA
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring$635,399
R01 · FY2021 · CA
Standardized Molecular Analyses of Glioma EVs$624,914
R01 · FY2021 · CA
Clinical platform for high-throughput analyses of extracellular vesicles$588,778
R01 · FY2021 · CA · contact PI
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$746,693
U01 · FY2020 · CA · contact PI
Clinical platform for high-throughput analyses of extracellular vesicles$702,900
R01 · FY2020 · CA · contact PI
Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring$660,849
R01 · FY2020 · CA
Standardized Molecular Analyses of Glioma EVs$649,034
R01 · FY2020 · CA
High-throughput Integrated Magneto-electrochemical Exosome (HiMEX) platform to identify neurodevelopmental markers associated with pre and postnatal oxycodone exposure$210,744
R21 · FY2020 · DA · contact PI
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$705,145
U01 · FY2019 · CA · contact PI
Clinical platform for high-throughput analyses of extracellular vesicles$565,123
R01 · FY2019 · CA · contact PI
High-throughput Integrated Magneto-electrochemical Exosome (HiMEX) platform to identify neurodevelopmental markers associated with pre and postnatal oxycodone exposure$247,330
R21 · FY2019 · DA · contact PI
Clinical platform for high-throughput analyses of extracellular vesicles$110,699
R01 · FY2019 · CA · contact PI
Clinical platform for high-throughput analyses of extracellular vesicles$42,165
R01 · FY2019 · CA · contact PI
Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics$759,263
U01 · FY2018 · CA · contact PI
Clinical platform for high-throughput analyses of extracellular vesicles$597,308
R01 · FY2018 · CA · contact PI
Multiplexed exosome analyses with DNA barcoding$199,856
R21 · FY2017 · CA · contact PI
MAGNETIC NANOSENSORS FOR BIOMEDICAL ANALYSES OF MICROVESICLES$434,933
R01 · FY2016 · HL · contact PI
Multiplexed exosome analyses with DNA barcoding$239,828
R21 · FY2016 · CA · contact PI
MAGNETIC NANOSENSORS FOR BIOMEDICAL ANALYSES OF MICROVESICLES$428,409
R01 · FY2015 · HL · contact PI
MAGNETIC NANOSENSORS FOR BIOMEDICAL ANALYSES OF MICROVESICLES$426,236
R01 · FY2014 · HL · contact PI
MAGNETIC NANOSENSORS FOR BIOMEDICAL ANALYSES OF MICROVESICLES$414,060
R01 · FY2013 · HL · contact PI
MAGNETIC NANOSENSORS FOR BIOMEDICAL ANALYSES OF MICROVESICLES$436,184
R01 · FY2012 · HL · contact PI